The Panel updated the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. Highlights from the updated section are summarized below:
Mycobacterium tuberculosis
The Panel on Antiretroviral Guidelines for Adults and Adolescents (the Panel) updated the following sections of the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV. Highlights are summarized below:
The U.S. Preventive Services Task Force posted a final research plan on pre-exposure prophylaxis (PrEP) for the prevention of HIV infection. The draft research plan for this topic was posted for public comment from November 4 through December 8, 2021. …
Free, virtual exercise classes for persons living with HIV and aged 50+ can help improve your strength, balance and overall fitness. Sign up for evidence-based exercise programs offered through CJE SeniorLife’s Research Institute through two grants provided by the Administration …
Today, the U.S. Food and Drug Administration approved Apretude (cabotegravir extended-release injectable suspension) for use in at-risk adults and adolescents weighing at least 35 kilograms (77 pounds) for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV. Apretude …
The HIV League Scholarship — the only national scholarship for students living with HIV — is accepting applications for the 2022 round until January 31 at 11:59 p.m. Eastern Time.
Here are the criteria for an individual to apply for …
A peer workgroup formed by the Illinois Public Health Association and the Public Health Institute of Metropolitan Chicago put together a video of self expression about World AIDS Day and what it means to them. “David, Steve, Chris, Peter, Roger” …
Effective Dec. 1, 2021, the Illinois Department of Public Health will switch dispensing pharmacies on the Ryan White Medication Assistance Program (MAP/ADAP) from CVS to Walgreens. The new Illinois MAP/ADAP pharmacy network will increase your access to prescription dispensing services …
HIV.gov’s updated Clinical Info Mobile App gives access to federally approved treatment and research information for HIV and AIDS, developed for mobile devices and provided free of charge. The application is comprised of three modules: federally approved medical practice …
…